Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us
Looking for representation? Submit a free inquiry →

John Beaulieu — Petitioner Attorney, U.S. Vaccine Court

Petitioner attorney U.S. Court of Federal Claims · Office of Special Masters Last verified
Cases filed
31
Comp rate
71%
Total awarded
$2.3M
Years active
2024–2026
FirmsSiri & Glimstad, LLP (31)
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the attorney directly or with source court records before relying on them.

About John Beaulieu

John Beaulieu is a vaccine injury attorney at Siri & Glimstad LLP, based in the firm's Louisville, Kentucky office. He earned his J.D. from Syracuse University College of Law in 2017 and his B.A. in Economics and Political Science from Kenyon College, and previously served as a Kentucky public defender for over six years, handling serious felony jury trials and contested hearings before transitioning to vaccine injury practice.

AI-generated overview · may contain errors. Verify details with the attorney directly before relying on them.
Sources: [1]

VICP practice summary

John Beaulieu is a petitioner attorney with the U.S. Court of Federal Claims, Office of Special Masters, who has filed 31 petitions in the National Vaccine Injury Compensation Program (VICP) between 2024 and 2026. The practice focuses on SIRVA (shoulder injury related to vaccine administration) (19 cases, 84% comp rate) and Guillain-Barré Syndrome (GBS) (10 cases, 50% comp rate), among other vaccine-related injuries. Cases filed by John Beaulieu have resulted in $2.3M in total compensation awards (71% compensation rate across all petitions). Practice has been associated with Siri & Glimstad, LLP.

Practice pattern

Comp rate by condition

SIRVA (shoulder injury related to vaccine administration)-6pt
19 cases · 16 compensated
This attorney
84%
Program
90%
Guillain-Barré Syndrome (GBS)-34pt
10 cases · 5 compensated
This attorney
50%
Program
84%

Comp rate by vaccine

Influenza-2pt
23 cases · 19 compensated
This attorney
83%
Program
85%

Frequently asked questions about John Beaulieu

Answers built from this attorney's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or browse this index to research individual attorneys' case histories.
Who is John Beaulieu?
John Beaulieu is a petitioner attorney with the U.S. Court of Federal Claims, Office of Special Masters, who represents petitioners in the National Vaccine Injury Compensation Program (VICP). The VICP Registry shows 31 petitions filed by John Beaulieu between 2024 and 2026.
How many VICP cases has John Beaulieu filed?
John Beaulieu has filed 31 petitions in the National Vaccine Injury Compensation Program according to the VICP Registry. Of these, 22 resulted in compensation, for an overall compensation rate of 71%.
What is John Beaulieu's VICP compensation rate?
John Beaulieu's overall compensation rate across all VICP petitions is 71% (22 compensated cases out of 31 total).
What is the total amount awarded in cases filed by John Beaulieu?
Cases filed by John Beaulieu have resulted in $2.3M in total compensation awards from the U.S. Vaccine Injury Compensation Program. This figure reflects only awards visible in published Court of Federal Claims decisions; settlements with non-public terms are not included.
What types of vaccine injury cases does John Beaulieu typically handle?
Based on case data in the VICP Registry, John Beaulieu's practice includes SIRVA (shoulder injury related to vaccine administration), Guillain-Barré Syndrome (GBS), among other vaccine-related conditions. The full case history is available on this page.
What law firm is John Beaulieu associated with?
John Beaulieu has been associated with Siri & Glimstad, LLP in cases filed under the National Vaccine Injury Compensation Program.
FiledDecidedPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2024-10-212026-03-16Kimberly RiceJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$60,000
2024-10-042026-03-09Robert BergJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$30,000
2024-08-082026-02-12Genaro FloresJohn BeaulieuSiri & Glimstad LLP–influenzaGuillain-Barre Syndrome (GBS)compensatedBrian H. Corcoran$150,994
2024-01-262026-02-04Judith MoranJohn BeaulieuSiri & Glimstad, LLP–influenzaleft shoulder injury related to vaccine administration (SIRVcompensatedBrian H. Corcoran$62,160
2024-08-292026-01-05Leon GulleyJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$35,000
2023-10-112025-12-22Robert NewellJohn BeaulieuSiri & Glimstad, LLP–influenzaGuillain-Barre syndromecompensatedBrian H. Corcoran$120,000
2024-10-242025-12-19Tommy E. MartinJohn BeaulieuSiri & Glimstad LLP57.6yhepatitis Ashoulder injury related to vaccine administration (SIRVA)entitlement_granted_pending_damagesBrian H. Corcoran–
2025-03-212025-11-24Craig SmitJohn BeaulieuSiri & Glimstad, LLP–influenzaGuillain-Barre syndrome (GBS)entitlement_granted_pending_damagesBrian H. Corcoran–
2023-08-152025-11-10Maria V. Paltrinieri BacliniJohn BeaulieuSiri & Glimstad LLP–influenza and tetanus, diphtheGuillain-Barre syndromecompensatedBrian H. Corcoran$124,138
2024-01-122025-10-30Roberto RiveraJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$67,500
2024-01-122025-10-22Lynda FieldsJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$100,000
2024-01-302025-10-22Kristen McLaughlinJohn BeaulieuSiri & Glimstad LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$110,000
2025-03-072025-10-10Annie AkersJohn BeaulieuSiri & Glimstad, LLP–influenza; Tdapshoulder injury related to vaccine administration (SIRVA)entitlement_granted_pending_damagesBrian H. Corcoran–
2022-01-282025-10-03M.K.John BeaulieuSiri & Glimstad, LLP12.0yTdap; meningococcal conjugatesystemic juvenile idiopathic arthritis (sJIA)deniedBrian H. Corcoran–
2023-11-292025-09-04Timothy HoltJohn BeaulieuSiri & Glimstad LLP–influenzaGuillain-Barre syndromecompensatedBrian H. Corcoran$264,092
2025-06-092025-08-26A.S.John BeaulieuSiri & Glimstad, LLP–influenzaGuillain-Barre SyndromecompensatedBrian H. Corcoran$169,553
2024-08-052025-08-22Quailer SessumsJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$43,000
2023-10-032025-08-19Sandra Yadira Camacho CazarezJohn BeaulieuSiri & Glimstad LLP––shoulder injury related to vaccine administration (SIRVA) andismissedBrian H. Corcoran–
2025-07-162025-08-19Tapan RoyJohn BeaulieuSiri & Glimstad LLP–influenzaGuillain-Barré syndromeentitlement_granted_pending_damagesBrian H. Corcoran–
2022-12-302025-08-12Danielle SpillerJohn BeaulieuSiri & Glimstad, LLP43.0yinfluenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$77,566
2024-11-122025-07-22Janice WeilJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$62,500
2024-12-302025-07-11Kanijha Johnson-McFarlandJohn BeaulieuSiri & Glimstad, LLP–human papillomavirus (HPV)Guillain-Barre syndromedismissedBrian H. Corcoran–
2024-07-252025-07-02Rebecca TaylorJohn BeaulieuSiri & Glimstad LLP–pneumococcal conjugate vaccineshoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$115,979
2022-12-232025-06-13James StanfieldJohn Beaulieu, Andrew Donald DowningSiri & Glimstad LLP; Downing, Allison & Jorgenson–influenza vaccineGuillain-Barre syndrome (GBS)compensatedBrian H. Corcoran$408,125
2024-08-282025-05-13Cristina NovoaJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$57,348
2023-09-282025-04-24Misty FullerJohn BeaulieuSiri & Glimstad LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$17,000
2025-03-122025-04-17Anthony FarrellJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$87,279
2025-03-072025-04-07David TomalaJohn BeaulieuSiri & Glimstad, LLP–influenzaGuillain-Barré Syndromeentitlement_granted_pending_damagesBrian H. Corcoran–
2023-08-242024-10-09Leora ChasenJohn BeaulieuSiri & Glimstad LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$77,653
2024-08-132024-09-25Andrew WilliamsonJohn BeaulieuSiri & Glimstad LLP–influenzaGuillain-Barré syndromedismissedBrian H. Corcoran–
2023-01-272024-08-13Elsie BoriaJohn BeaulieuSiri & Glimstad, LLP–influenzashoulder injury related to vaccine administration (SIRVA)compensatedBrian H. Corcoran$45,000